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Available online 23 April 2016Coronary artery disease (CAD) is the leading cause of mortality in the end-stage renal disease. Although risk of
myocardial infarction (MI) decreases after renal transplantation compared to hemodialysis period, CAD remain
the major cause of mortality after transplantation also. Risk of MI is maximal during the perioperative period
and it's incidence decreases gradually after transplantation. Pre-operative cardiac evaluation is essential prior
to renal transplantion. Herein, we prensented a case of acute anterior myocardial infarction observed in the
early post-operative period of renal transplantation and review the current literature. We discussed the demo-
graphic and clinical predictors of the perioperative cardiac events.
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Coronary artery disease (CAD) is the leading cause of mortality in
end-stage renal disease (ESRD), hence ESRD is accepted as the equiva-
lent of CAD. Although risk of myocardial infarction (MI) decreases
after renal transplantation compared to the hemodialysis period, CAD
remains the major clinical issue regarding mortality.1 Risk of MI is at
peak during the perioperative period and its incidence decreases gradu-
ally after transplantation.1 Effective preoperative cardiac evaluation
prior to renal transplantation may prevent the possible cardiac compli-
cation in the perioperative period. Herein, we presented a case of acute
anterior MI observed in the early postoperative transplantation period
and discussed the perioperative risk assessment and management.
Case report
A 57-year-oldmale patient was admitted to hospital for renal trans-
plantation. Onmedical background, he had been followed upwith a di-
agnosis of polycystic kidney disease and he was taking hemodialysis
therapy for 10 years. Coronary bare metal stent (3.0 × 20mm) was im-
planted to the proximal left anterior descending artery (LAD) a year ago
and he was free from anginal symptoms for a year. He was a current
smoker and also under medication for hypertension. Physical examina-
tion did not show speciﬁc pathology and functional capacity was more
than 7 METS. He also did not deﬁne typical anginal chest pain on exer-
tion. Laboratory data showed dyslipidemia with LDL cholesterol
150mg/dl. Aspirin therapywas discontinued for a week and the patientdiovascular Academy.
y. Production and hosting by Elsevdid not take any additional antiagregant therapy. Live donor transplan-
tation was performed without any complication. In the postoperative
period, the patient deﬁned atypical chest pain which was not thought
as an acute cardiac event. But, there was not any ischemic ﬁnding in
the ECG. The patient was discharged from the hospital on the seventh
postoperative day. However, the patient was readmitted to hospital
on the same day with a complaint of typical chest pain, palpitation,
and shortness of breath. ECG showed anterior ST elevation and the pa-
tient was transferred to a catheter laboratory for primary coronary in-
terventions. Coronary angiography revealed thrombotic critical lesions
in the mid and distal LAD (Fig. 1A). Angioplasty and stent deployment
was performed to LAD lesion (Fig. 1B). Bare metal stent was preferred
by the operator to shorten the dual antiplatelet therapy. Heparin
60 unit/kg was given prior to angioplasty and was not continued after
procedure. The patient was discharged without any complication in-
cluding bleeding and additional renal pathology. Dual antiplatelet ther-
apy consists of acetylsalicylic acid 100 mg and clopidogrel 75 mg daily
was prescribed for a month. One-year follow-up of the patient was un-
eventful with functional renal graft.
Discussion
Kidney transplantation is associated with 17% risk reduction for
myocardial infarction (MI) compared to patients in the waiting list.1
However,MI remains a leading cause of death in patientswith function-
ing renal transplantation. The risk of MI is highest in the early postoper-
ative period and mortality rates after hospitalization for MI is
approximately 50% at 5 years, which affects allograft longevity also.1
Perioperative cardiac events might occur as a result of demand-
mediated ischemia and/or plaque rupture. A detailed preoperative car-
diac assessment should be performed to cover both clinical issues.2ier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND license
Fig. 1.A. Left anterior oblique projection showing thrombotic subtotal lesion inmid left anterior descending artery and thrombotic 70% lesion in the distal segment. B. Left anterior oblique
projection showing successful percutaneous coronary interventions.
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described. Nonetheless, renal allograft recipients have higher prevalence
of traditional atherosclerotic risk factors. The risk factors for posttrans-
plantation period might be deﬁned as age N 60,obesity, smoking, left
ventricular hypertrophy, diabetes, hypertension, and dyslipidemia.2–3
Besides traditional risk factors, male gender, time on dialysis before
transplantation (Na year), donor history of hypertension, transplantation
from older donor, immunosuppressive regimen, quality of allograft func-
tion, and posttransplantation diabetes also are proposed as predictors of
cardiovascular risk in this population.3–4 Both Framingham risk score and
European Society of Cardiology Score chart can be used to determine risk
for cardiovascular disease especially in low-risk patients. Framingham
risk score may underestimate cardiovascular risk in the high-risk
patients.5 CT coronary angiography has a high negative predictive value
in screening of CAD and it would be an ideal screening test in low- to in-
termediate-risk patients. However, coronary calciﬁcation is usuallywide-
spread in the ESRD, which may interfere with the sensitivity and
speciﬁcity of the study.2 Myocardial perfusion scintigraphy or dobuta-
mine stress echocardiography is the primarily recommended noninva-
sive tests for asymptomatic high-risk patients. Despite, both studies
may give useful information in the assessment of coronary ischemia me-
diated by demand-blood supply discrepancy, theywould not predict car-
diac events secondary to plaque rupture.2 Thus, modiﬁcation of risk
factors and effective medical therapy prior to surgery may diminish the
acute thrombotic ischemic events. In addition, preoperative coronary an-
giographymight be a logical approach for assessing cardiovascular risk in
symptomatic high-risk patients. Our case was already diagnosed
CAD and also possess traditional risk factors including hypertension,
dyslipidemia, and smoking. Relatively longer dialysis time and immuno-
suppressive therapy are the other risk factors for cardiac complications.
Preoperative coronary angiography would be logical to show patency of
stent regarding our case. On contrary, preoperative angiography would
not predict the acute coronary events for our patients. Because LAD
stent was already patent and preoperative angiography would not
change the transplantation schedule, efﬁcacy of preoperative cardiac re-
vascularization was also not clear. Lifestyle modiﬁcation including cessa-
tion of smoking and regular exercise and also regulation of medical anti-
ischemic agents would be the most important prognostic factors to pre-
vent perioperative coronary events for our patient. On the other hand,
postoperative routine screening of troponin I levels may also be beneﬁ-
cial for diagnosing cardiac complication. Although abnormal troponin
level is highly prevalent following renal transplantation, normal troponin
levels had a high negative predictive value in excluding patients likely todevelop postoperative MI.6 Troponin level was not checked in our pa-
tients despite atypical chest pain deﬁnition.
Early postoperative percutaneous coronary intervention is associat-
ed with bleeding complication because of dual antiplatelet therapy plus
heparin. It was reported that thrombus aspiration and lone balloon an-
gioplasty may be logical in the selected cases.7 However, our case char-
acteristic was not suitable for both strategy because of tight thrombotic
subtotal lesion in the mid LAD. The operator preferred bare metal stent
to shorten dual antiplatelet therapy. Bare metal stents are the classical
choice in the intervention before the transplantation surgery for shorter
dual antiplatelet therapy. A small case series show that, kidney trans-
plant surgery may performed under antiplatelet therapy with lower
bleeding complication contrary to general consensus of discontinuation
of antiplatelet therapy for 5 days.2,8 Drug eluting stents (DES) are supe-
rior to BMS in terms of restenosis and acute coronary events also in the
patients with ESRD. Compared to older DES, new-generation DES
showed less stent thrombosis with shorter dual antiplatelet therapy.9
Palmerini T et al demonstrated that major adverse cardiac events
were similar with the 3-month and 12-month antiplatelet therapy in
the new-generation DES era.10 We think that dual antiplatelet therapy
is not a limitation for renal transplantation recipients and DES should
replace traditional BMS implantation in ESRD patients regardless of
the time of transplantation.
Conclusion
Acutemyocardial infarction is a major cause of mortality in the peri-
operative period of renal transplantation. A detailed preoperative as-
sessment of cardiac status, effective preoperative anti-ischemic
therapy including lifestyle management and preoperative coronary an-
giography in the symptomatic high-risk patients, will preventmortality
and provide allograft longevity.
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